Oakley Capital Investments Limited has announced its investment in vitroconnect, a leading broadband open access platform business in Germany. The investment is made through Oakley Capital Origin II, marking its first platform investment. The indirect contribution to Origin II from OCI is anticipated to be up to £19 million. vitroconnect connects broadband providers with resellers through a proprietary, single interface software platform, offering process automation, network operations, brokerage, and white-label services. The company has shown consistent and profitable double-digit growth over the last three years and is poised to benefit from the significant proliferation of fibre to the home technology in Germany.
The investment in vitroconnect aligns with Oakley Capital's track record of partnering with high growth and profitable founder-led businesses. Oakley Capital co-founder and Managing Partner Peter Dubens expressed confidence in vitroconnect's market leading position and its potential to benefit from the transformational change in Germany's broadband market. The founder and CEO of vitroconnect, Dirk Pasternack, expressed excitement about partnering with Oakley and embarking on the next stage of vitroconnect's growth plan.
The transaction is subject to regulatory approval and is expected to complete around the end of H1 2024. Oakley's investment in vitroconnect further adds to its long track record of partnering with high growth and profitable founder-led businesses. The company has a strong track record in the software and telco space and is known for guiding companies through inflection points. Oakley looks forward to working with vitroconnect's team to further accelerate its growth.
Oakley Capital Investments Limited is a Specialist Fund Segment traded investment vehicle that aims to provide shareholders with consistent long-term capital growth. The investment in vitroconnect is in line with Oakley's strategy to provide liquid access to private equity returns through investment in the Oakley Funds.